RABIES
Clinical trials for RABIES explained in plain language.
Never miss a new study
Get alerted when new RABIES trials appear
Sign up with your email to follow new studies for RABIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could fewer shots prevent rabies? new trial tests simpler vaccine schedules
⭐️ VACCINE ⭐️ OngoingThis phase 3 trial is testing whether simpler vaccination schedules for rabies are as effective as the standard 5-dose regimen. About 3,000 healthy people aged 10 to 60 will receive the vaccine in different patterns, including fewer total doses. Researchers will measure immune re…
Matched conditions: RABIES
Phase: PHASE3 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:03 UTC
-
One shot to stop rabies? new vaccine trial begins
⭐️ VACCINE ⭐️ OngoingThis study tests a new rabies vaccine called ChAdOx2 RabG, given as a single shot. It involves 174 healthy adults (18-45 years) and young children (2-6 years) in a country where rabies is common. The goal is to see if the vaccine is safe and triggers a strong immune response, com…
Matched conditions: RABIES
Phase: PHASE1, PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:57 UTC
-
New antibody cocktail aims to stop rabies after multiple dog bites
Prevention OngoingThis study looks at whether a new antibody injection, called zamerovimab and mazorelvimab, combined with the standard rabies vaccine, can prevent rabies in people who have been severely bitten by a dog. The trial follows 80 adults in China for up to one year to see if they stay r…
Matched conditions: RABIES
Sponsor: Synermore Biologics (Suzhou) Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC